Diabetic Retinopathy: Know the Signs, Symptoms and Treatments

A disease that steals a person’s eyesight is one of the many potential complications of diabetes. Learn why eye care is crucial.

7:00 AM

Author | Kevin Joy

Left unchecked, diabetes can affect almost every part of the body — from skin and bone to the heart, liver and nerves.

A common and vulnerable target: the eyes.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

About 30 to 40 percent of patients with diabetes in the United States experience diabetic retinopathy, which occurs when high blood sugar damages the tiny blood vessels of the retina.

The severity is tied to the duration and management of a patient's diabetes. Over time, advanced cases can lead to poor vision or even blindness.

That's why preventive self-care and regular eye exams are important, says Thomas Gardner, M.D., a professor of ophthalmology at the University of Michigan Kellogg Eye Center.

"Like most other diseases, success lies in early diagnosis and treatment," says Gardner. "The prognosis for retaining good vision for people who keep their diabetes well controlled is much, much better than it used to be."

Why diabetic retinopathy is dangerous

Many people aren't aware they have diabetic retinopathy until it has moved from early stages (nonproliferative retinopathy) to a point when leaking blood vessels break open and cause scar tissue that can pull on the retina (proliferative retinopathy). A delayed or lack of treatment "can make it very difficult to maintain vision," Gardner says.

Diabetic retinopathy symptoms

The condition is often asymptomatic, especially in early cases. But as it progresses, effects are pronounced — including a lessened (or lost) ability to read or drive. Gardner says patients also may start "seeing blood floating around in their eyes" in the form of tiny black or red dots.

SEE ALSO: 5 Questions with a Diabetes Physician Who Has Type 1

How diabetic retinopathy is diagnosed

Patients should notify a doctor if symptoms arise, but dilation during a routine eye exam can offer clues: "Most commonly, we see small hemorrhages in the back of their eye," Gardner says. "We also can see if there is swelling of the retina or growth of abnormal blood vessels."

Who is at risk of diabetic retinopathy

People with type 1 and type 2 diabetes generally have the same likelihood of developing diabetic retinopathy. Blacks and Hispanics have a higher overall risk. Secondary factors, Gardner says, also heighten the chances: "foot infections, anemia or coexisting kidney disease."

How diabetic retinopathy is treated

Steroids and medications known as anti-vascular endothelial growth factor (anti-VEGF) can help. "Steroids reduce inflammation, and the anti-VEGF drugs inhibit the action of a specific molecule inside the eye that promotes leaking blood vessels — and the formation of abnormal new ones," Gardner says. Some patients may be advised to receive laser eye treatment.

Ways to prevent diabetic retinopathy

Habits that patients with diabetes use to maintain their health also keep diabetic retinopathy at bay: exercise, smoking and alcohol cessation, and a balanced diet, among other things. "The earlier you set a good foundation, the more likely you are to do well," Gardner says.


More Articles About:

Eye Health Diabetes Management Diabetes Support Kellogg Eye Center Eye Care & Vision Diabetes
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Michael Powers pictured here holding a fish he caught as he stands in a boat. He struggled with pancreatitis for several decades and found answers at University of Michigan Health.
Health Lab

Patient with rare form of diabetes finds answers in genetic testing, clinical trials

Discover how genetic testing and a groundbreaking clinical trial helped one man overcome rare hyperchylomicronemia, high triglycerides, and pancreatitis.
Research image of rat blood vessels before and after norrin treatment
Health Lab

Treatment with norrin helped maintain healthy blood vessels, preserved vision in diabetic rats

Study reveals norrin treatment prevents vision loss from diabetic retinopathy in early and late stages, paving the way for new therapies.
A pill bottle is open and pills are placed onto a hand
Health Lab

Could a diabetes medication be the next wonder drug?

Researchers identified how sotagliflozin may reduce heart attack and stroke risk, potentially offering benefits beyond diabetes care
Gene editing, conceptual illustration. DNA (deoxyribonucleic acid) double helix under a magnifying glass
Health Lab

Gene editing is coming for common diseases. Are we ready?

Gene therapies may offer one-time treatment for disease, but experts say safety, reversibility, cost and long-term monitoring must guide use.
Adam Jacobson, M.D., uses ophthalmology equipment to examine the eyes of a pediatric patient.
Philanthropy News

Innovative children’s vision research gets a boost from the Knights Templar Eye Foundation

A $2 million gift from the Knights Templar Eye Foundation, Inc., will support innovative pediatric vision research and care at the Kellogg Eye Center.
Minding memory above a microphone on a blue background
Minding Memory

Is the United States Lagging Behind Europe in Memory Improvement?

In this episode, Lauren & Matt speak with Neil Mehta, PhD who is the associate dean for research and a professor in the Department of Epidemiology at the University of Texas Medical Branch in Galveston. Dr. Mehta’s research focuses on US life expectancy trends, the effects of obesity on disability and mortality, the sources of socioeconomic status disparities in mortality, and patterns of health in the United States and Europe. Dr. Mehta talks about a recent manuscript from the NIA-funded TRENDS study called “Trends in Memory Function and Memory Impairment Among Older Adults in the United States and Europe, 1996 to 2018.”, which looks at data from several sources to compare trends in memory function across 13 different countries.